Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetRevenue - Other
Ratios

Aclaris Therapeutics (ACRS) Receivables - Other (2017 - 2021)

Aclaris Therapeutics has reported Receivables - Other over the past 4 years, most recently at $24000.0 for Q4 2021.

  • Quarterly results put Receivables - Other at $24000.0 for Q4 2021, down 92.0% from a year ago — trailing twelve months through Dec 2021 was $24000.0 (down 92.0% YoY), and the annual figure for FY2021 was $24000.0, down 92.0%.
  • Receivables - Other for Q4 2021 was $24000.0 at Aclaris Therapeutics, up from $20000.0 in the prior quarter.
  • Over the last five years, Receivables - Other for ACRS hit a ceiling of $300000.0 in Q2 2020 and a floor of -$570000.0 in Q4 2017.
  • Median Receivables - Other over the past 4 years was $62000.0 (2019), compared with a mean of $62500.0.
  • Biggest five-year swings in Receivables - Other: skyrocketed 200.0% in 2020 and later crashed 92.0% in 2021.
  • Aclaris Therapeutics' Receivables - Other stood at -$570000.0 in 2017, then soared by 117.54% to $100000.0 in 2019, then skyrocketed by 200.0% to $300000.0 in 2020, then crashed by 92.0% to $24000.0 in 2021.
  • The last three reported values for Receivables - Other were $24000.0 (Q4 2021), $20000.0 (Q1 2021), and $300000.0 (Q4 2020) per Business Quant data.